← USPTO Patent Grants

Cancer vaccines

Grant US12582609B2 Kind: B2 Mar 24, 2026

Assignee

ModernaTX, Inc.

Inventors

Nicholas Valiante, Tal Zaks, Eric Yi-Chun Huang

Abstract

The disclosure relates to cancer ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

CPC Classifications

A61K 39/0011 A61K 2039/53 A61K 39/001114 A61K 9/10 A61K 9/5123 A61K 2039/545 A61K 2039/55588 A61P 35/00

Filing Date

2016-10-21

Application No.

15769710

Claims

36